Logistics & Supply Chain Technology

Delta X

Portfolio Overview

BioSynthesis: Advancing Biotechnology for a Sustainable Future

BioSynthesis is a premier biotechnology company leveraging cutting-edge synthetic biology platforms to address critical environmental and healthcare challenges. The company engineers advanced microorganisms to produce high-value bio-based materials, pharmaceuticals, and renewable chemicals. BioSynthesis’s proprietary platform, SynBioLab, facilitates high-efficiency genetic engineering and bioprocessing, significantly accelerating the market delivery of sustainable alternatives to traditional petrochemicals.

Spanning high-impact sectors such as agriculture, healthcare, and industrial manufacturing, BioSynthesis is pioneering commercially viable, eco-friendly solutions designed to mitigate fossil fuel reliance and drive institutional sustainable practices.

Key Strategic Focus Areas


  • Sustainable Bio-Production: BioSynthesis engineers top-tier renewable chemicals and novel performance materials to displace petrochemical inputs, driving transition toward a circular green economy.

  • Pharmaceutical and Biologics Innovation: The firm develops scalable microbial expression systems for producing essential pharmaceuticals and complex biologics, optimizing therapeutic accessibility and supply chains.

Executive Leadership and Founders


  1. Dr. Elena Orlov (CEO & Co-Founder): A distinguished biochemist and sustainability advocate, Dr. Orlov leads the corporate vision of utilizing advanced biotechnology to address systemic global challenges.

  2. Markus Fischer (CTO & Co-Founder): Leveraging deep expertise in genetic engineering, Mr. Fischer spearheads BioSynthesis’s technological roadmaps and synthetic biology innovations.


Investment Thesis and Capital Impact

Backed by institutional capital from EcoBiotech Ventures, BioSynthesis has successfully scaled its SynBioLab platform, materially enhancing production throughput and diversifying its product suite into high-growth verticals like biofuels and engineered biodegradable plastics, reinforcing its commitment to high-impact environmental stewardship.

Metrics & Analytics

150%

Revenue Growth Rate

5-to-1 ratio

LTV:CAC Ratio

$2,000

Monthly Burn Rate